Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. AML Therapy With Irradiated Allogeneic Cells

    ... platelet count 150,000 to 440,000/mm^3 DONOR: hemoglobin / hematocrit ; 12.5-18 g/dl, 38 to 54% DONOR: not ...

    Clinical Trial last updated 06/13/2016 - 3:14pm.

  2. Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children

    ... of the lung for carbon monoxide (DLCO) (corrected for hemoglobin ) of < 60% predicted; patients who are unable to perform ...

    Clinical Trial last updated 06/13/2016 - 2:29pm.

  3. Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 (DFCI 10-106)

    ... ANC <1,000 cells/mm3, within 21 days of registration Hemoglobin <8 g/dL, within 21 days of registration Hepatic impairment ...

    Clinical Trial last updated 05/23/2016 - 3:45pm.

  4. StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

    ... (diffusion capacity) >50% of predicted (corrected for hemoglobin ); if unable to perform pulmonary function tests, then normal O2 ...

    Clinical Trial last updated 06/03/2016 - 2:37pm.

  5. Extended Dosing With Eltrombopag for Severe Aplastic Anemia

    ... in platelet count 34,000/micro l), six had improved hemoglobin levels (median increase of 3.8g/dL), including three previously ...

    Clinical Trial last updated 04/26/2016 - 9:36am.

  6. Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies

    ... FEV1, FVC and DLCO >/= 50% of expected, corrected for hemoglobin . Adequate liver function: a. Bilirubin </= 1.5 mg/dl ...

    Clinical Trial last updated 06/06/2016 - 1:18pm.

  7. Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    ... diffusion capacity of least 50% predicted, corrected for hemoglobin . Patient or patient's legal representative, able to sign ...

    Clinical Trial last updated 06/06/2016 - 12:41pm.

  8. Safety and Effect of GL-ONC1 Administered IV With or Without Eculizumab Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery

    ... 100 × 109 (without platelet transfusion ); Hemoglobin ≥ 9.0 g/dL(with or without red blood cell (RBC) ...

    Clinical Trial last updated 04/28/2016 - 1:57pm.

  9. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    ... if symptomatic, DLCO > 50% of predicted (corrected for hemoglobin ) Each patient must be willing to participate as a ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.

  10. Overlap Syndromes: When PNH Appears with Aplastic Anemia or MDS

    ... This could be due to a few things – the acquired hemoglobin -H syndrome, or acquired pyruvate kinase deficiency for example. ...

    Interview last updated 05/14/2015 - 1:53pm.